HomeAUTL • NASDAQ
Autolus Therapeutics PLC
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 8.98M | -10.99% |
Operating expense | 29.53M | 62.48% |
Net income | -70.16M | -33.16% |
Net profit margin | -781.13 | -49.60% |
Earnings per share | -0.26 | -9.83% |
EBITDA | -62.96M | -70.39% |
Effective tax rate | -3.28% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 516.58M | -31.90% |
Total assets | 746.34M | -17.21% |
Total liabilities | 375.23M | 17.48% |
Total equity | 371.11M | — |
Shares outstanding | 266.14M | — |
Price to book | 1.37 | — |
Return on assets | -21.33% | — |
Return on capital | -23.19% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -70.16M | -33.16% |
Cash from operations | -75.57M | -86.52% |
Cash from investing | -59.55M | -11,072.05% |
Cash from financing | — | — |
Net change in cash | -131.55M | -125.34% |
Free cash flow | -70.61M | -63.22% |
Previous close
$1.91
Day range
$1.94 - $2.13
Year range
$1.11 - $5.00
Market cap
560.23M USD
Avg Volume
2.34M
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
649
